UPL Announces Collaboration With Meiji for Exclusive Access to Flupyrimin Rice in Southeast Asia
May 11 2021 - 12:54AM
Business Wire
UPL Ltd., a global provider of sustainable agriculture
solutions, today announced that its subsidiary has entered into a
license agreement with Japanese company, Meiji Seika Pharma Co.,
Ltd. for exclusive access to Flupyrimin for rice in Southeast
Asia.
Under the license agreement, UPL will obtain exclusive rights to
develop, register and commercialize formulations of Flupyrimin for
foliar applications in rice in Southeast Asia, expanding the
on-going collaboration between the two companies with this
compound.
In addition to this latest arrangement, in 2018 UPL’s subsidiary
and Meiji entered into an exclusive licensing agreement for UPL to
commercialize formulations of Flupyrimin for applications in rice
in India. Furthermore, in 2020, the two companies signed a
long-term global commercial exclusive agreement, excluding Japan,
South Korea and Taiwan and non-exclusive in China, to use
Flupyrimin in seed treatment and in-furrow applications.
Flupyrimin, discovered by Meiji, is a patented active ingredient
and the only AI in the new mode of action subgroup, Pyridylidenes,
defined by IRAC in 2021. It is a novel insecticide with unique
biological properties that, among other benefits, is effective
against major rice pests, such as brown plant hopper and rice stem
borer, including those populations resistant to existing
insecticides.
Together, both companies will continue their contributions to
the development of differentiated solutions based on Flupyrimin to
address farmer pain points and improve their livelihoods.
“We are pleased to expand our relationship with Meiji regarding
Flupyrimin in this mutually beneficial collaboration to provide
growers in Southeast Asia access to this important AI. Our OpenAgTM
Purpose opens the door to developing and expanding key
relationships that create sustainable growth for all and ensure
farmer resilience,” said Jai Shroff, CEO of UPL. “Meiji is an
important partner to UPL, and we look forward to continuing our
collaboration, creating a win, win.”
“The UPL agreement is a significant step forward towards
providing growers with differentiated solutions that address their
challenges in the field. We are excited to continue to strengthen
our relationship with UPL to deliver this innovative and effective
AI to farmers in Southeast Asia,” said Daikichiro Kobayashi,
President and Representative Director
ABOUT UPL
UPL Ltd. (NSE: UPL & BSE: 512070) is a global provider of
sustainable agriculture products & solutions, with annual
revenue exceeding $5 billion. We are a purpose-led company. Through
OpenAg, UPL is focused on facilitating progress for the entire
agricultural value chain. We are building a network that redefines
the way an entire industry thinks and works – open to fresh ideas,
innovative ways and new answers as we strive towards our mission to
make each food product more sustainable. As one of the largest
agriculture solutions companies worldwide, our robust portfolio
consists of biologicals and traditional crop protection solutions
with over 13,600 registrations. We are present in over 130
countries, represented by more than 10,000 colleagues globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210510006058/en/
Radhika Arora Head of Investor Relations UPL Ltd.
Radhika.Arora@upl-ltd.com
Ultra Petroleum (NASDAQ:UPL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ultra Petroleum (NASDAQ:UPL)
Historical Stock Chart
From Sep 2023 to Sep 2024